These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
434 related items for PubMed ID: 27531512
1. Dithiazole thione derivative as competitive NorA efflux pump inhibitor to curtail multi drug resistant clinical isolate of MRSA in a zebrafish infection model. Lowrence RC, Raman T, Makala HV, Ulaganathan V, Subramaniapillai SG, Kuppuswamy AA, Mani A, Chittoor Neelakantan S, Nagarajan S. Appl Microbiol Biotechnol; 2016 Nov; 100(21):9265-9281. PubMed ID: 27531512 [Abstract] [Full Text] [Related]
2. Ferulic acid derivative inhibits NorA efflux and in combination with ciprofloxacin curtails growth of MRSA in vitro and in vivo. Sundaramoorthy NS, Mitra K, Ganesh JS, Makala H, Lotha R, Bhanuvalli SR, Ulaganathan V, Tiru V, Sivasubramanian A, Nagarajan S. Microb Pathog; 2018 Nov; 124():54-62. PubMed ID: 30118803 [Abstract] [Full Text] [Related]
3. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus. Mahey N, Tambat R, Chandal N, Verma DK, Thakur KG, Nandanwar H. Microbiol Spectr; 2021 Dec 22; 9(3):e0095121. PubMed ID: 34908453 [Abstract] [Full Text] [Related]
4. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase. Chan BC, Ip M, Lau CB, Lui SL, Jolivalt C, Ganem-Elbaz C, Litaudon M, Reiner NE, Gong H, See RH, Fung KP, Leung PC. J Ethnopharmacol; 2011 Sep 01; 137(1):767-73. PubMed ID: 21782012 [Abstract] [Full Text] [Related]
5. Evaluation of expression of NorA efflux pump in ciprofloxacin resistant Staphylococcus aureus against hexahydroquinoline derivative by real-time PCR. Pourmand MR, Yousefi M, Salami SA, Amini M. Acta Med Iran; 2014 Sep 01; 52(6):424-9. PubMed ID: 25130148 [Abstract] [Full Text] [Related]
13. Discovery of novel dihydronaphthalene-imidazole ligands as potential inhibitors of Staphylococcus aureus multidrug resistant NorA efflux pump: A combination of experimental and in silico molecular docking studies. A Malik A, Dangroo NA, Kaur P, Attery S, A Rather M, Khan A, Ara T, Nandanwar H. Microb Pathog; 2024 May 01; 190():106627. PubMed ID: 38521473 [Abstract] [Full Text] [Related]
15. Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus. Vidaillac C, Guillon J, Arpin C, Forfar-Bares I, Ba BB, Grellet J, Moreau S, Caignard DH, Jarry C, Quentin C. Antimicrob Agents Chemother; 2007 Mar 01; 51(3):831-8. PubMed ID: 17101679 [Abstract] [Full Text] [Related]
17. Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance. Sabatini S, Gosetto F, Iraci N, Barreca ML, Massari S, Sancineto L, Manfroni G, Tabarrini O, Dimovska M, Kaatz GW, Cecchetti V. J Med Chem; 2013 Jun 27; 56(12):4975-89. PubMed ID: 23710549 [Abstract] [Full Text] [Related]